Reports surrounding the health history of the British royal family have resurfaced, this time centering on claims about Prince Philip. According to a new biography, the late royal may have been diagnosed with pancreatic cancer years before his passing, a revelation that has sparked both intrigue and skepticism.
In Queen Elizabeth II: A Personal History, author Hugo Vickers alleges that Prince Philip was diagnosed with inoperable pancreatic cancer in 2013, nearly eight years before his death in April 2021. The claim adds to a growing narrative around health concerns within the royal family, including recent battles faced by King Charles III and Catherine, Princess of Wales.
However, the reported timeline has raised eyebrows within the medical community. Specialists have questioned the likelihood of such long-term survival in cases involving pancreatic cancer, particularly when described as inoperable. One expert noted that surviving eight years under those conditions would be “highly unusual,” prompting speculation that the case, if accurate may have involved a less aggressive or atypical form of the disease.
Pancreatic cancer is widely regarded as one of the most aggressive and difficult-to-detect cancers, often diagnosed at advanced stages due to its subtle early symptoms. The most common form, pancreatic adenocarcinoma, typically carries a five-year survival rate of just 5–10 percent. That reality has led some medical professionals to suggest that a rarer subtype, such as a neuroendocrine tumor, could explain a longer survival window.
Vickers recounts that doctors had identified a “shadow” on Prince Philip’s pancreas and performed exploratory surgery, ultimately concluding the cancer was inoperable. At the time, it was believed the Duke would withdraw from public life entirely. Yet, in what the author describes as characteristic resilience, he continued to make appearances and lived for several more years.
Despite the renewed attention, Buckingham Palace has not confirmed these claims or provided details regarding Prince Philip’s health prior to his death. Similarly, the palace has remained private about the specific nature of King Charles III’s current cancer diagnosis.
The reports contribute to ongoing public curiosity about the health of the royal family, a subject that has increasingly moved into the spotlight in recent years, blending personal privacy with global interest.
Comments are closed.